Easiest way to think about is Assets = Liabilities + Equity
Equity is current market cap of $521.5m. You acquire the company by owning all outstanding shares but also take on the debt which is $143m. To have full claim over Myer you will also need to pay back the debt of $143m. So total cost is $664.5m.
Furthermore, given FY EBITDA = $198.10m and using a 5x leverage multiple then private equity could potentially take over Myer at a total cost = $990.50m. This would equate to a share price of $1.03
EBITDA $198.10m x 5 = $990.50m
-> PE cost $990.50m - outstanding debt of $143m = $847.50m (equity offer value)
Hence, $847.50m/ 821.3m shares outstanding = $1.03
This is just illustrative, I don't think the value is there to be honest. The EBITDA has to be sustainable for a PE to be interested.
- Forums
- ASX - By Stock
- MYR
- Premier starts move against Myer board
MYR
myer holdings limited
Add to My Watchlist
1.65%
!
61.5¢

Premier starts move against Myer board, page-14
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
61.5¢ |
Change
0.010(1.65%) |
Mkt cap ! $1.062B |
Open | High | Low | Value | Volume |
60.0¢ | 62.5¢ | 59.8¢ | $3.415M | 5.582M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 19696 | 61.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
62.5¢ | 92228 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6118 | 0.605 |
13 | 319011 | 0.600 |
7 | 60403 | 0.595 |
18 | 222579 | 0.590 |
10 | 91829 | 0.585 |
Price($) | Vol. | No. |
---|---|---|
0.630 | 120060 | 4 |
0.635 | 66114 | 2 |
0.640 | 8130 | 1 |
0.645 | 10000 | 1 |
0.650 | 91182 | 7 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
MYR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online